These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15682316)

  • 1. Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure.
    Clark RG
    Pediatr Nephrol; 2005 Mar; 20(3):290-4. PubMed ID: 15682316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure.
    Roelfsema V; Clark RG
    J Am Soc Nephrol; 2001 Jun; 12(6):1297-1306. PubMed ID: 11373355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH, IGF-I, and growth.
    Isaksson O
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
    Collett-Solberg PF; Misra M;
    J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I in growth and metabolism.
    Backeljauw P; Bang P; Dunger DB; Juul A; Le Bouc Y; Rosenfeld R
    J Pediatr Endocrinol Metab; 2010; 23(1-2):3-16. PubMed ID: 20432800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I).
    Bright GM; Fierro-Renoy JF
    Growth Horm IGF Res; 2020 Jun; 52():101318. PubMed ID: 32252003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ; Rogol AD
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant IGF-I: Past, present and future.
    Bright GM
    Growth Horm IGF Res; 2016 Jun; 28():62-5. PubMed ID: 26822565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
    Kemp SF
    BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
    Rosenbloom AL
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IGF system: new developments relevant to pediatric practice.
    Rosenfeld RG
    Endocr Dev; 2005; 9():1-10. PubMed ID: 15879683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of primary IGF-1 deficiency in Egyptian children with idiopathic short stature.
    Anwar GM; Kandeel WA; Mandour IA; Kamal AN
    Horm Res Paediatr; 2013; 79(5):277-82. PubMed ID: 23635650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone axis in chronic kidney disease.
    Mahesh S; Kaskel F
    Pediatr Nephrol; 2008 Jan; 23(1):41-8. PubMed ID: 17676425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of primary insulin-like growth factor-I deficiency: current perspectives and clinical update.
    Backeljauw P; Bang P; Clayton PE; Geffner M; Woods KA
    Pediatr Endocrinol Rev; 2010 Feb; 7 Suppl 1():154-71. PubMed ID: 20463651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.